Bioconjugates to specifically render inhibitors water-soluble

被引:30
作者
Hirsch, Anna K. H. [1 ]
Diederich, Francois [1 ]
Antonietti, Markus [2 ]
Boerner, Hans G. [2 ]
机构
[1] ETH, Organ Chem Lab, HCI, CH-8093 Zurich, Switzerland
[2] Max Planck Inst Colloids & Interfaces, D-14476 Potsdam, Germany
基金
瑞士国家科学基金会;
关键词
DEOXYXYLULOSE PHOSPHATE-PATHWAY; CATECHOL-O-METHYLTRANSFERASE; ABL TYROSINE KINASE; ISOPRENOID BIOSYNTHESIS; AQUEOUS SOLUBILITY; NONMEVALONATE PATHWAY; POLYMERIC MICELLES; CRYSTAL-STRUCTURE; RATIONAL DESIGN; DRUG;
D O I
10.1039/b915928b
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
Polymer-peptide conjugates are utilised to render small-molecule inhibitors of the kinase IspE, a promising new antimalarial target, water-soluble. It is shown that the peptide sequence of poly( ethylene oxide)-peptide conjugates can be tailored to mediate specific interactions with the ligands, allowing the solubilisation of even highly challenging inhibitors. This strategy avoids compromising the inhibitor structure to afford water solubility and potentially enables the exploration of a greater structural space of both inhibitors and drugs.
引用
收藏
页码:88 / 91
页数:4
相关论文
共 56 条
[1]   The correlation and prediction of the solubility of compounds in water using an amended solvation energy relationship [J].
Abraham, MH ;
Le, J .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1999, 88 (09) :868-880
[2]   Bioinspired functional block copolymers [J].
Boerner, Hans G. ;
Schlaad, Helmut .
SOFT MATTER, 2007, 3 (04) :394-408
[3]   Strategies exploiting functions and self-assembly properties of bioconjugates for polymer and materials sciences [J].
Boerner, Hans G. .
PROGRESS IN POLYMER SCIENCE, 2009, 34 (09) :811-851
[4]   The role of lateral gene transfer in the evolution of isoprenoid biosynthesis pathways [J].
Boucher, Y ;
Doolittle, WF .
MOLECULAR MICROBIOLOGY, 2000, 37 (04) :703-716
[5]  
Broers S. T. J., 1994, THESIS ETH ZURICH SW
[7]   Predicting aqueous solubility from structure [J].
Delaney, JS .
DRUG DISCOVERY TODAY, 2005, 10 (04) :289-295
[8]   Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells [J].
Druker, BJ ;
Tamura, S ;
Buchdunger, E ;
Ohno, S ;
Segal, GM ;
Fanning, S ;
Zimmermann, J ;
Lydon, NB .
NATURE MEDICINE, 1996, 2 (05) :561-566
[9]   Lessons learned from the development of an Abl tyrosine kinase inhibitor for chronic myelogenous leukemia [J].
Druker, BJ ;
Lydon, NB .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (01) :3-7
[10]   Prediction of properties from simulations: Free energies of solvation in hexadecane, octanol, and water [J].
Duffy, EM ;
Jorgensen, WL .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2000, 122 (12) :2878-2888